Literature DB >> 19426726

Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields.

Matthew N Hill1, Richard G Hunter, Bruce S McEwen.   

Abstract

Exposure to chronic stress has been found to decrease cannabinoid CB(1) receptor expression in the hippocampus; however, the specificity of this phenomenon to specific subfields of the hippocampus has not been characterized. To this extent, male Sprague-Dawley rats were exposed to 21 days of restraint stress (6 h/day), after which autoradiographical analysis of cannabinoid CB(1) receptor binding site densities were examined in the CA1, CA3 and dentate gyrus subfields of the hippocampus. Chronic stress was found to produce a significant reduction in cannabinoid CB(1) receptor binding in the dentate gyrus, while increasing cannabinoid CB(1) receptor binding in the CA3. There was no effect of chronic stress on cannabinoid CB(1) receptor binding in the CA1, or two other proximal regions, the retrosplenial cortical gyrus and the laterodorsal thalamus. Given the role of hippocampal cannabinoid CB(1) receptor activity in the maintenance of synaptic integrity and neuroplasticity in the hippocampus, these data suggest that changes in cannabinoid CB(1) receptor activity following stress may contribute to stress-induced modulation of these processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426726      PMCID: PMC2746437          DOI: 10.1016/j.ejphar.2009.04.048

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.

Authors:  Matthew N Hill; Erica J Carrier; Ryan J McLaughlin; Anna C Morrish; Sarah E Meier; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

2.  Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.

Authors:  A Ameri; T Simmet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-03       Impact factor: 3.000

3.  Social stress exacerbates stroke outcome by suppressing Bcl-2 expression.

Authors:  A C DeVries; H D Joh; O Bernard; K Hattori; P D Hurn; R J Traystman; N J Alkayed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 4.  Plasticity of the hippocampus: adaptation to chronic stress and allostatic load.

Authors:  B S McEwen
Journal:  Ann N Y Acad Sci       Date:  2001-03       Impact factor: 5.691

5.  Effects of chronic stress on hippocampal long-term potentiation.

Authors:  Constantine Pavlides; Lucas G Nivón; Bruce S McEwen
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

Review 6.  Modulation of transmitter release via presynaptic cannabinoid receptors.

Authors:  E Schlicker; M Kathmann
Journal:  Trends Pharmacol Sci       Date:  2001-11       Impact factor: 14.819

Review 7.  Mossy cells in epilepsy: rigor mortis or vigor mortis?

Authors:  Annad d H Ratzliff; Vijayalakshmi Santhakumar; Allyson Howard; Ivan Soltesz
Journal:  Trends Neurosci       Date:  2002-03       Impact factor: 13.837

8.  Acute and chronic restraint stress alter the incidence of social conflict in male rats.

Authors:  Gwendolyn E Wood; L Trevor Young; Lawrence P Reagan; Bruce S McEwen
Journal:  Horm Behav       Date:  2003-01       Impact factor: 3.587

Review 9.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

10.  Endocannabinoids facilitate the induction of LTP in the hippocampus.

Authors:  Gregory Carlson; Yue Wang; Bradley E Alger
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

View more
  8 in total

1.  Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus.

Authors:  Jaclyn I Wamsteeker; J Brent Kuzmiski; Jaideep S Bains
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 2.  Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.

Authors:  Diana Dow-Edwards; Ashley Frank; Dean Wade; Jeremy Weedon; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2016-09-12       Impact factor: 3.763

Review 3.  Stress regulates endocannabinoid-CB1 receptor signaling.

Authors:  Cecilia J Hillard
Journal:  Semin Immunol       Date:  2014-05-29       Impact factor: 11.130

4.  Brain CB₁ receptor expression following lipopolysaccharide-induced inflammation.

Authors:  H Hu; W Ho; K Mackie; Q J Pittman; K A Sharkey
Journal:  Neuroscience       Date:  2012-10-04       Impact factor: 3.590

5.  Involvement of Nrf2 in development of anxiety-like behavior by linking Bcl2 to oxidative phosphorylation: estimation in rat hippocampus, amygdala, and prefrontal cortex.

Authors:  Solmaz Khalifeh; Shahrbanoo Oryan; Hadi Digaleh; Fatemeh Shaerzadeh; Fariba Khodagholi; Nader Maghsoudi; Mohammad-Reza Zarrindast
Journal:  J Mol Neurosci       Date:  2014-07-11       Impact factor: 3.444

6.  Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.

Authors:  Irena Smaga; Beata Bystrowska; Dawid Gawliński; Bartosz Pomierny; Piotr Stankowicz; Małgorzata Filip
Journal:  Neurotox Res       Date:  2014-03-21       Impact factor: 3.911

7.  In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.

Authors:  Faith Borgan; Heikki Laurikainen; Mattia Veronese; Tiago Reis Marques; Merja Haaparanta-Solin; Olof Solin; Tarik Dahoun; Maria Rogdaki; Raimo Kr Salokangas; Max Karukivi; Marta Di Forti; Federico Turkheimer; Jarmo Hietala; Oliver Howes
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

Review 8.  The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.

Authors:  Tibor M Brunt; Matthijs G Bossong
Journal:  Eur J Neurosci       Date:  2020-12-05       Impact factor: 3.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.